Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.
Authors
Brundage, MSydes, M
Parulekar, W
Warde, P
Cowan, Richard A
Bezjak, A
Kirkbride, P
Parliament, M
Moynihan, C
Bahary, J
Parmar, M
Sanders, K
Chen, B
Mason, M
Affiliation
Queen's Cancer Research Institute and Cancer Centre of Southeastern OntarioIssue Date
2015-05-26
Metadata
Show full item recordAbstract
The NCIC CTG PR3/MRC PR07 randomized phase III trial compared androgen-deprivation therapy (ADT) alone versus ADT with radiotherapy (RT) for patients with locally advanced prostate cancer. This article reports the health-related quality-of-life (HRQOL) outcomes of this trial.Citation
Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial. 2015: J Clin OncolJournal
Journal of Clinical OncologyDOI
10.1200/JCO.2014.57.8724PubMed ID
26014295Type
ArticleLanguage
enISSN
1527-7755ae974a485f413a2113503eed53cd6c53
10.1200/JCO.2014.57.8724